Pierantonio Menna - Concepedia

Author

Pierantonio Menna

Università Campus Bio-Medico ORCID

Also Known As

Menna, P, P Menna, P. Menna, Pierantonio MENNA, Pierantonio Menna

Publications

5.9K

Citations

H-Index

Concepts

All Affiliations

Università Campus Bio-Medico University of Chieti-Pescara Istituti di Ricovero e Cura a Carattere Scientifico Campus Bio Medico University Hospital Menarini Group (Italy)

About

Pierantonio Menna is an author at Università Campus Bio-Medico specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	613
2	Natural Sciences	3	3	116
3	Biochemistry	3	3	294
4	Health Sciences	1	1	11
5	Cell Biology	1	1	200

Pierantonio Menna

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Doxorubicin irreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes: evidence for distinct metabolic pathways and implications for iron-mediated cardiotoxicity of antitumor therapy. Giorgio Minotti, Raffaella Ronchi, Emanuela Salvatorelli, PubMed Iron MetabolismCardiovascular ToxicityDox MetabolismRedox BiologyOxidative Stress	2001	200
Cardiotoxicity of Antitumor Drugs Pierantonio Menna, Emanuela Salvatorelli, Giorgio Minotti Chemical Research in Toxicology Heart FailureOncologyAntitumor DrugsMany Antitumor DrugsMedicine	2008	160
Defective One- or Two-electron Reduction of the Anticancer Anthracycline Epirubicin in Human Heart Emanuela Salvatorelli, Simone Guarnieri, Pierantonio Menna, Journal of Biological Chemistry	2006	92
Pharmacological Foundations of Cardio-Oncology Giorgio Minotti, Emanuela Salvatorelli, Pierantonio Menna Journal of Pharmacology and Experimental Therapeutics	2010	85
Primary Prevention Strategies for Anthracycline Cardiotoxicity: A Brief Overview Pierantonio Menna, Emanuela Salvatorelli Chemotherapy Primary PreventionHeart FailurePreventive MedicineOncologyCardiovascular Disease	2017	80
Paclitaxel and Docetaxel Stimulation of Doxorubicinol Formation in the Human Heart: Implications for Cardiotoxicity of Doxorubicin-Taxane Chemotherapies Emanuela Salvatorelli, Pierantonio Menna, Sabrina Cascegna, Journal of Pharmacology and Experimental Therapeutics	2006	76
Anthracycline Metabolism and Toxicity in Human Myocardium: Comparisons between Doxorubicin, Epirubicin, and a Novel Disaccharide Analogue with a Reduced Level of Formation and [4Fe-4S] Reactivity of Its Secondary Alcohol Metabolite Giorgio Minotti, Sabrina Licata, A. Saponiero, Chemical Research in Toxicology	2000	75
Anthracycline Degradation in Cardiomyocytes: A Journey to Oxidative Survival Pierantonio Menna, Emanuela Salvatorelli, Giorgio Minotti Chemical Research in Toxicology	2009	65
Paclitaxel and docetaxel enhance the metabolism of doxorubicin to toxic species in human myocardium. Giorgio Minotti, A. Saponiero, Sabrina Licata, PubMed Doxorubicin CardiotoxicityHeart FailureCardiovascular PharmacologyPathologyPharmacotherapy	2001	63
The Novel Anthracenedione, Pixantrone, Lacks Redox Activity and Inhibits Doxorubicinol Formation in Human Myocardium: Insight to Explain the Cardiac Safety of Pixantrone in Doxorubicin-Treated Patients Emanuela Salvatorelli, Pierantonio Menna, Odalys Gonzalez Paz, Journal of Pharmacology and Experimental Therapeutics	2012	54

Page 1